X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-11 | ADPT | Rubinstein Julie | Pres, COO | S - Sale+OE | $13.21 | -179,703 | 507,934 | -26% | -$2,374,058 | |||||
2026-03-11 | ADPT | Griffin Michelle Renee | Dir | S - Sale | $13.91 | -15,394 | 15,625 | -50% | -$214,131 | ||||||
2026-03-11 | ADPT | Lo Francis | Chief People Officer | S - Sale | $14.08 | -30,593 | 293,874 | -9% | -$430,749 | ||||||
2026-03-11 | ADPT | Bobulsky Susan | Chief Commercial Officer, MRD | S - Sale | $13.17 | -41,338 | 427,775 | -9% | -$544,421 | ||||||
2026-03-11 | ADPT | Benzeno Sharon | Chief Commercial Ofc Imm Med | S - Sale | $13.17 | -63,103 | 272,751 | -19% | -$831,067 | ||||||
2026-03-11 | ADPT | Piskel Kyle | CFO | S - Sale | $13.17 | -18,672 | 259,840 | -7% | -$245,910 | ||||||
2026-03-11 | ADPT | Robins Harlan S | Chief Scientific Officer | S - Sale | $13.17 | -470,266 | 1,522,058 | -24% | -$6,193,403 | ||||||
2026-03-11 | ADPT | Robins Chad M | CEO, COB | S - Sale | $13.17 | -470,167 | 2,301,113 | -17% | -$6,192,099 | ||||||
| DM | 2026-03-06 | ADPT | Rubinstein Julie | Pres, COO | S - Sale+OE | $14.90 | -81,342 | 643,471 | -11% | -$1,211,737 | |||||
2026-03-05 | ADPT | Lo Francis | Chief People Officer | S - Sale | $15.09 | -38,074 | 324,467 | -11% | -$574,537 | ||||||
| D | 2026-03-03 | ADPT | Griffin Michelle Renee | Dir | S - Sale+OE | $15.30 | -48,044 | 15,394 | -76% | -$735,073 | |||||
| DM | 2026-03-03 | ADPT | Rubinstein Julie | Pres, COO | S - Sale+OE | $16.09 | -92,823 | 575,235 | -14% | -$1,493,428 | |||||
| M | 2026-03-02 | ADPT | Robins Harlan S | Chief Scientific Officer | S - Sale | $16.19 | -24,233 | 1,155,291 | -2% | -$392,329 | |||||
| M | 2026-02-27 | ADPT | Robins Chad M | CEO, COB | S - Sale | $15.85 | -524,998 | 1,934,247 | -21% | -$8,320,613 | |||||
| D | 2026-02-04 | ADPT | Piskel Kyle | CFO | S - Sale+OE | $18.46 | -2,145 | 216,637 | -1% | -$39,597 | |||||
| M | 2026-02-02 | ADPT | Robins Harlan S | Chief Scientific Officer | S - Sale | $18.68 | -42,788 | 1,179,524 | -4% | -$799,105 | |||||
2026-02-02 | ADPT | Robins Chad M | CEO, COB | S - Sale | $18.44 | -124,998 | 2,459,245 | -5% | -$2,304,963 | ||||||
| D | 2026-01-12 | ADPT | Lo Francis | Chief People Officer | S - Sale+OE | $17.73 | -79,590 | 318,478 | -20% | -$1,411,131 | |||||
| D | 2026-01-12 | ADPT | Piskel Kyle | CFO | S - Sale+OE | $18.00 | -4,290 | 216,637 | -2% | -$77,220 | |||||
2026-01-06 | ADPT | Robins Harlan S | Chief Scientific Officer | S - Sale | $16.44 | -10,000 | 1,222,312 | -1% | -$164,400 | ||||||
| AD | 2025-12-22 | ADPT | Lo Francis | Chief People Officer | S - Sale+OE | $17.50 | -4,394 | 318,478 | -1% | -$76,895 | |||||
2026-01-05 | ADPT | Robins Chad M | CEO, COB | S - Sale | $15.59 | -124,998 | 2,584,243 | -5% | -$1,948,719 | ||||||
| D | 2026-01-02 | ADPT | Lo Francis | Chief People Officer | S - Sale+OE | $16.08 | -3,125 | 318,478 | -1% | -$50,250 | |||||
| D | 2025-12-22 | ADPT | Lo Francis | Chief People Officer | S - Sale+OE | $17.50 | -4,394 | 318,478 | -1% | -$76,895 | |||||
| D | 2025-12-15 | ADPT | Lo Francis | Chief People Officer | S - Sale+OE | $15.57 | -113,890 | 318,478 | -26% | -$1,773,267 | |||||
2025-12-10 | ADPT | Hershberg Robert | Dir | S - Sale | $16.00 | -22,968 | 46,722 | -33% | -$367,488 | ||||||
| D | 2025-12-04 | ADPT | Benzeno Sharon | Chief Commercial Ofc Imm Med | S - Sale+OE | $16.85 | -12,604 | 296,791 | -4% | -$212,377 | |||||
| M | 2025-12-03 | ADPT | Robins Harlan S | Chief Scientific Officer | S - Sale | $18.07 | -37,212 | 1,232,312 | -3% | -$672,515 | |||||
| D | 2025-11-28 | ADPT | Piskel Kyle | CFO | S - Sale+OE | $19.50 | -162,820 | 216,637 | -43% | -$3,174,990 | |||||
| M | 2025-11-26 | ADPT | Robins Chad M | CEO, COB | S - Sale | $19.10 | -160,734 | 2,709,241 | -6% | -$3,070,747 | |||||
| DM | 2025-11-20 | ADPT | Benzeno Sharon | Chief Commercial Ofc Imm Med | S - Sale+OE | $16.73 | -606,402 | 296,791 | -67% | -$10,144,026 | |||||
2025-11-17 | ADPT | Piskel Kyle | CFO | S - Sale | $14.05 | -238 | 269,343 | 0% | -$3,344 | ||||||
2025-11-10 | ADPT | Robins Harlan S | Chief Scientific Officer | S - Sale | $14.82 | -10,000 | 1,269,524 | -1% | -$148,200 | ||||||
| M | 2025-11-10 | ADPT | Robins Chad M | CEO, COB | S - Sale | $14.73 | -89,265 | 2,869,975 | -3% | -$1,315,180 | |||||
| A | 2025-05-16 | ADPT | Piskel Kyle | CFO | S - Sale | $8.89 | -1,929 | 269,581 | -1% | -$17,149 | |||||
2025-05-16 | ADPT | Piskel Kyle | CFO | S - Sale | $8.89 | -1,929 | 277,396 | -1% | -$17,149 | ||||||
| D | 2025-05-01 | ADPT | Robins Harlan S | Chief Scientific Officer | S - Sale+OE | $7.35 | -68,412 | 1,279,524 | -5% | -$502,828 | |||||
| D | 2025-03-24 | ADPT | Robins Harlan S | Chief Scientific Officer | S - Sale+OE | $9.00 | -1,698 | 1,279,524 | 0% | -$15,282 | |||||
2025-03-13 | ADPT | Griffin Michelle Renee | Dir | S - Sale | $7.19 | -36,291 | 15,394 | -70% | -$260,932 | ||||||
2025-03-12 | ADPT | Hershberg Robert | Dir | S - Sale | $7.59 | -53,000 | 69,690 | -43% | -$402,270 | ||||||
| D | 2025-03-10 | ADPT | Neupert Peter M | Dir | S - Sale+OE | $7.05 | -10,000 | 224,690 | -4% | -$70,500 | |||||
| D | 2025-03-05 | ADPT | Lo Francis | Chief People Officer | S - Sale+OE | $6.99 | -20,875 | 335,346 | -6% | -$145,845 | |||||
| D | 2025-03-05 | ADPT | Bobulsky Susan | Chief Commercial Officer, MRD | S - Sale+OE | $6.98 | -26,023 | 347,238 | -7% | -$181,641 | |||||
| D | 2025-03-05 | ADPT | Benzeno Sharon | Chief Commercial Ofc Imm Med | S - Sale+OE | $6.98 | -44,665 | 392,723 | -10% | -$311,792 | |||||
2025-03-05 | ADPT | Piskel Kyle | CFO | S - Sale | $6.98 | -10,320 | 269,010 | -4% | -$72,072 | ||||||
2025-03-05 | ADPT | Rubinstein Julie | Pres, COO | S - Sale | $6.98 | -59,505 | 588,249 | -9% | -$415,540 | ||||||
2025-03-05 | ADPT | Robins Harlan S | Chief Scientific Officer | S - Sale | $6.99 | -96,656 | 1,279,524 | -7% | -$675,219 | ||||||
| M | 2025-03-05 | ADPT | Robins Chad M | CEO, COB | S - Sale | $7.29 | -219,569 | 2,959,249 | -7% | -$1,600,417 | |||||
| D | 2025-03-06 | ADPT | Griffin Michelle Renee | Dir | S - Sale+OE | $7.94 | -15,664 | 51,685 | -23% | -$124,372 | |||||
| DM | 2025-02-19 | ADPT | Robins Chad M | CEO, COB | S - Sale+OE | $8.45 | -285,187 | 2,576,701 | -10% | -$2,410,700 | |||||
| DM | 2025-02-13 | ADPT | Robins Chad M | CEO, COB | S - Sale+OE | $8.47 | -470,368 | 2,576,701 | -15% | -$3,985,754 | |||||
2024-11-18 | ADPT | Piskel Kyle | CFO | S - Sale | $4.98 | -248 | 154,330 | 0% | -$1,235 | ||||||
2024-08-22 | ADPT | Taylor Stacy L | SVP, GC | S - Sale | $4.50 | -26,922 | 139,365 | -16% | -$121,079 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |